Pharming Group to report fourth quarter and full year 2023 financial results on March 14
29 Febbraio 2024 - 8:00AM
Pharming Group to report fourth quarter and full year 2023
financial results on March 14
Leiden, The Netherlands, February 29,
2024: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its
preliminary (unaudited) fourth quarter and full year 2023 financial
results, for the period ended December 31, on Thursday, March 14,
2024.Pharming will host a presentation for analysts and investors
at 13:30 CET/08:30 am EDT on March 14, 2024.To participate in the
conference call, please register in advance using the link below.
Once registered, dial-in information and a unique PIN will be
provided, allowing access to the call.
Conference call
registration:
Please note, the Company will only take
questions from dial-in attendees.
https://register.vevent.com/register/BIc993931aa2d54aa89d594b2cad5ed972
To watch the live webcast, please register in
advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/5wi4ajdm
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules, biologics, and
gene therapies that are in early to late-stage development.
Pharming is headquartered in Leiden, Netherlands, and has employees
around the globe who serve patients in over 30 markets in North
America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, The
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696E:
investor@pharming.com
FTI Consulting, London, UKVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
Grafico Azioni Pharming Group NV (TG:PHGN)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Pharming Group NV (TG:PHGN)
Storico
Da Nov 2023 a Nov 2024
